ALEXANDRIA REAL EST. EQU./ US0152711091 /
20/12/2024 15:29:01 | Chg. -2.7800 | Volume | Bid22:00:00 | Demandez à22:00:00 | Capitalisation boursière | Dividende Y. | Rapport P/E |
---|---|---|---|---|---|---|---|
92.5400EUR | -2.92% | 112 Chiffrre d'affaires: 10,632.4000 |
-Bid taille: - | -Ask la taille: - | 16.62 Mrd.EUR | - | - |
GlobeNewswire
20/10/2023
SHARC Energy at Forefront of Alexandria’s Sustainable Mega Campus Initiative
GlobeNewswire
21/09/2023
Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross
GlobeNewswire
23/02/2022
Intellia Therapeutics Enters Lease Agreement to Build Manufacturing Facility for its CRISPR-based Th...
GlobeNewswire
21/10/2021
Orange Grove Bio, AlleyCorp and Alexandria Venture Investments Establish Partnership with Albert Ein...
GlobeNewswire
21/09/2021
Adaptive Biotechnologies Announces Grand Opening of State-of-the-Art Headquarters and Expands Footpr...
GlobeNewswire
13/05/2021
TCR² Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire
29/03/2021
TCR² Therapeutics Establishes Commercial-Scale Cell Therapy Manufacturing Facility
GlobeNewswire
24/02/2021
Life Science Cares and Biogen Foundation Help Launch Food For Free’s Just Eats Program
GlobeNewswire
12/08/2020
Beam Therapeutics Announces First Development Candidates for Sickle Cell Disease and Reports Second ...
GlobeNewswire
14/11/2019
Sarepta and StrideBio Announce Multi-target Strategic Collaboration to Advance Novel Gene Therapies
- La première page
- Retour
- 1
- 2
- Suivant
- La dernière page